ARCHIVES

NIH scientists defend industry ties while officials vow conflicts review; three investigations planned.

This article is from The Cancer Letter archive.

Vol. 30 No. 04 | January 23, 2004

Download PDF Visit The Full Archive

Related Articles

Drug Reimbursement: Senate Bill Worse For Oncologists

July 11, 1997

New P01 Guidelines Will Go Into Effect Feb. 1 Not Oct. 1

September 16, 1983

Wyden Asks Healy To Clarify CRADA Pricing Clause

January 3, 1992

Cooperative Groups Pursue Contracts With Insurers, NCI Warns of Competition

June 14, 1996

U.S., Canada Begin ExCel Trial To Evaluate Aromasin For Breast Cancer Prevention

April 29, 2005

NSABP Objects to “Closed Process” For Review Of P-4 Breast Cancer Chemoprevention Trial.

April 20, 2007